ARTICLE | Clinical News
LEU-derived Mo-99 regulatory update
July 20, 2009 7:00 AM UTC
FDA and Health Canada approved applications for LEU-derived Mo-99 as a medical radioisotope for molecular and nuclear diagnostic imaging procedures for several types of imaging, including brain, thyro...